A review: Emphasis on the connection between hormones modifiable plasma lipids and metabolism of lipid in obesity

Monika Singh, Abhishek . Kumar, Moumita . Barmanb

Abstract


Lipid dysfunction directly related with the obesity because increased low-density lipoprotein and triglyceride level elevated causes obesity by various mechanism. Many complications produce due to disturb metabolism of fatty acid and transferring in between various tissues. Current effort sophisticatedly established impaired fatty acid insnaring in obese persons. Additionally, overweight individuals have declined acceptance of nutritional fat through adipose tissue primary level due to this reason low-density lipoprotein level increase in the blood circulation as well as in liver. In this review authors discussed about the condition amongst hormones regulating plasma lipids and metabolism of lipid in obesity.

Keywords


Weight loss, obesity, receptor, hormone, Enzyme.

Full Text:

PDF

References


(1)- Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CR, Shimizu T, Spener F, van Meer G, Wakelam MJ, Dennis EA (April 2009). "Update of the LIPID MAPS comprehensive classification system for lipids". Journal of Lipid Research. 50 (S1): S9-14. doi:10.1194/jlr.R800095-JLR200. PMC 2674711. PMID 19098281.

(2)- Subramaniam S, Fahy E, Gupta S, Sud M, Byrnes RW, Cotter D, Dinasarapu AR, Maurya MR (October 2011). "Bioinformatics and systems biology of the lipidome". Chemical Reviews. 111 (10): 6452 90. doi:10.1021/cr200295k. PMC 3383319. PMID 21939287.

(3) Mashaghi S, Jadidi T, Koenderink G, Mashaghi A (February 2013). "Lipid nanotechnology". International Journal of Molecular Sciences. 14 (2): 4242–82. doi:10.3390/ijms14024242. PMC 3588097. PMID 23429269.

(4 ) - Michelle A, Hopkins J, McLaughlin CW, Johnson S, Warner MQ, LaHart D, Wright JD (1993). Human Biology and Health. Englewood Cliffs, New Jersey, USA: Prentice Hall. ISBN 978-0-13-981176-0. (5)DanielGyamfi, Enoch Ofori Awuah and Stephen Owusu Department of Medical Diagnostics, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

(6)By WILLIAM E. M. LANDS Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan

(7)Matthieu Moncan, 1 Katarzyna Mnich, 1 Arnaud Blomme, 2 Aitor Almanza, 1 Afshin Samali, 1 and Adrienne M. Gorman. Regulation of lipid metabolism by the unfolded protein response .J Cell Mol Med. 2021 Feb; 25(3): 1359–1370. Published online 2021 Jan 4. doi: 10.1111/jcmm.16255 ,PMCID: PMC7875919

(8) Michele Alves-Bezerra and David E. Cohen, Joan & Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA, 2017 Dec 12, doi: 10.1002/cphy.c170012

(9) Hyeong-Kyu Park and Rexford S. Ahima Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism, 2014 Aug 15. doi: 10.1016/j.metabol.2014.08.004

(10) Minokoshi, Yasuhiko; Toda, Chitoku; Okamoto, Shiki, Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle, Indian Journal of Endocrinology and Metabolism 2012 Dec; 16(Suppl 3): S562–S568.doi: 10.4103/2230-8210.105573 PMCID:PMC3602985 , PMID:23565491

(11) G. Schulman, Liver X receptors link lipid metabolism and inflammation, Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA, USA, First published: 27 May 2017, https://doi.org/10.1002/1873-3468.12702.

(12) Muhammad Wasim, Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan, Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan, http://dx.doi.org/10.4172/2165-7904.1000258, Obes Weight Loss Ther 2015

(13) Kawano, J., & Arora, R. (2009). The Role of Adiponectin in Obesity, Diabetes, and Cardiovascular Disease. Journal of the CardioMetabolic Syndrome, 4(1), 44–49. doi:10.1111/j.1559-4572.2008.00030.x

(14) Carmine Finelli and Giovanni Tarantino, What is the role of adiponectin in obesity related non-alcoholic fatty liver disease, World J Gastroenterol. 2013 Feb 14; 19(6): 802–812.Published online 2013 Feb 14. doi: 10.3748/wjg.v19.i6.802

(15) Mary L. Williams,'**.tGopinathan K. Menon,* and Karen P. Hanley"Dermatology Service,* Veterans Administration Medical Center, San Francisco, CA 94121, and Departments of Dermatology* and Pediatrics,? University of California San Francisco, journal of lipid research , Volume 33, Issue 2, February 1992, Pages 193-208, https://doi.org/10.1016/S0022-2275(20)41539-1 ,

(16) Ira J. Goldberg, Diabetic Dyslipidemia: Causes and Consequences, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 3, 1 March 2001, Pages 965–971, https://doi.org/10.1210/jcem.86.3.7304

(17) Elizabeth N Pearce, Hypothyroidism and dyslipidemia: modern concepts and approaches, Boston University Medical Center, 88 East Newton Street, Evans 201, Boston, MA 02118, USA. [email protected] , 2004 Nov;6(6):451-6. doi: 10.1007/s11886-004-0054-3.

(18) Megan Herink, Pharm.D., BCPS Assistant Clinical Professor, College of Pharmacy, Oregon State University/Oregon Health & Sciences University College of Pharmacy. 503-494-1187.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Pharmacology